Exhibit 107
Calculation of Filing Fee Tables
Schedule TO
(Rule 14d-100)
BIODELIVERY SCIENCES INTERNATIONAL, INC.
(Name of Subject Company (Issuer))
COLLEGIUM PHARMACEUTICAL, INC.
(Names of Filing Persons (Offerors))
Table 1-Transaction Valuation
Transaction Valuation* | Fee rate | Amount of Filing Fee | ||||||||||
Fees to Be Paid | $ | 1,196,312,079.36 | .0000927 | $ | 110,898.13 | |||||||
Fees Previously Paid | 0 | 0 | ||||||||||
Total Transaction Valuation | $ | 1,196,312,079.36 | ||||||||||
Total Fees Due for Filing | $ | 110,898.13 | ||||||||||
Total Fees Previously Paid | 0 | |||||||||||
Total Fee Offsets | 0 | |||||||||||
Net Fee Due | $ | 110,898.13 |
*Estimated for purposes of calculating the amount of the filing fee only. The transaction valuation was calculated by adding the sum of (i) 102,084,213 shares of common stock, par value $0.001 per share (“Shares”), issued and outstanding of BioDelivery Sciences International, Inc., a Delaware corporation (“BDSI”), multiplied by the offer price of $5.60 per Share, (ii) 1,223,900 Shares issuable pursuant to outstanding time-vested restricted stock units multiplied by the offer price of $5.60 per Share, (iii) 2,051,033 Shares issuable pursuant to outstanding warrants with an exercise price less than $5.60, multiplied by $3.04, which is $5.60 minus the weighted average price for such warrants of $2.56, and (iv) the net offer price for options to purchase 12,268,229 Shares with an exercise price less than $5.60 per Share (which is calculated by multiplying the number of Shares underlying such in-the-money stock options by an amount equal to $5.60 per Share minus the weighted average exercise price of $3.84 per Share). The foregoing share figures have been provided by BDSI are as of February 17, 2022, the most recent practicable date.